台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    42.30
  • 漲跌
    ▼0.40
  • 漲幅
    -0.94%
  • 成交量
    132
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
生華科 (6492)籌碼相關-玉山-新竹 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

玉山-新竹 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/2000.001841.3641.65-18378-4.76%
2025/01/1300.001242.9642.35-12384-3.12%
2025/01/10644.5700.0043.3563871.55%
2025/01/09944.6100.0043.9593862.33%
2024/12/311842.6700.0043.50184104.38%
2024/12/27245.0000.0044.2524210.47%
2024/12/2500.001042.3542.60-10441-2.26%
2024/12/0900.00343.3243.80-3600-0.50%
2024/11/21145.0000.0045.6516710.15%
2024/11/20245.1000.0045.1026820.29%
2024/11/18144.2000.0044.1016990.14%
2024/11/15546.7400.0046.2556960.72%
2024/11/1400.00646.6746.45-6705-0.85%
2024/11/061049.4000.0049.35107461.34%
2024/10/301051.80150.8050.5097771.16%
2024/10/29253.20352.0752.10-1772-0.13%
2024/10/2817.154.8913.154.1252.6047560.52%
2024/10/2500.000.354.4054.40-0.3645-0.05%
2024/10/161050.1000.0050.60109611.04%
2024/10/0900.00449.0049.15-41,059-0.38%
2024/09/302454.8200.0054.40241,0462.29%
2024/09/271054.900.254.9054.709.81,0350.95%
2024/09/250.354.3000.0053.800.31,0180.03%
2024/09/24154.30153.4053.4001,0190.00%
2024/09/19155.2000.0053.2019950.10%
2024/09/1300.00148.6547.80-1967-0.10%
2024/09/12347.00247.0547.3019790.10%
2024/09/11146.25247.4046.65-11,006-0.10%
2024/09/10347.0700.0046.9031,0390.29%
2024/09/0900.00247.5548.20-21,034-0.19%
2024/09/06147.2500.0046.5511,0230.10%
2024/09/05247.3500.0047.4021,0180.20%
2024/08/28050.30250.2050.30-2981-0.20%
2024/08/26350.73449.6549.65-1971-0.10%
2024/08/2200.00149.8049.80-1962-0.10%
2024/08/2000.00150.8050.90-1943-0.11%
2024/08/19150.3000.0049.8019300.11%
2024/08/1600.00150.1050.10-1928-0.11%
2024/08/15449.89149.6049.6039170.33%
2024/08/0600.00350.0049.00-3841-0.36%
2024/08/01355.5700.0055.4038040.37%
2024/07/30256.5000.0056.0027940.25%
2024/07/29156.0000.0056.9017880.13%
2024/07/2600.00153.1054.50-1776-0.13%
2024/07/233.155.5100.0054.103.17700.40%
2024/07/1900.00561.2058.10-5735-0.68%
2024/07/18561.40158.2062.2046580.61%
2024/07/16157.00357.0057.20-2427-0.47%
2024/07/0100.000.147.4047.10-0.1302-0.02%
2024/06/2800.000.447.5047.10-0.4299-0.12%
2024/06/2600.00248.8548.75-2288-0.69%
2024/06/2400.00146.2545.50-1262-0.38%
2024/06/21146.1500.0045.2012580.39%
2024/06/20247.90348.2347.60-1250-0.40%
2024/06/19444.912946.5347.95-25224-11.12%
2024/06/18845.1900.0044.0082133.74%
2024/06/172145.3000.0045.352118711.22%
2024/06/1200.000.241.8541.80-0.2152-0.12%
2024/05/090.142.0000.0041.350.11800.04%
2024/04/2200.00140.6040.65-1187-0.53%
2024/04/19140.6000.0040.7011860.54%
2024/04/02243.6500.0043.9521921.04%
2024/04/01045.0500.0044.4001930.00%
2024/03/280.143.8600.0043.400.11990.05%
2024/03/250.244.6500.0044.500.22010.09%
2024/03/21042.9000.0042.7002000.00%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音